Close Menu

NEW YORK – Sema4 said on Wednesday that it has raised $121 million in an oversubscribed Series C financing round, giving the genetic testing and data analysis firm a valuation of over $1 billion.

BlackRock, the world's largest investment manager, led the round and was joined by new investors Deerfield Management and Moore Strategic Ventures and existing investors Blackstone, Section 32, Oak HC/FT, Decheng Capital, and the Connecticut Innovation Fund. Deerfield Partner Andrew Elbardissi has joined Sema4's board of directors.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.